Deadline for submission of applications: 31/12/2016
Reference: Vall d’Hebron Institute of Oncology’s Molecular Oncology Group. Barcelona, Spain
Number of vacancies: 1
Offer description:
We are currently inviting applications for the appointment of a Pathologist to join our Molecular Oncology Group at the Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Our group has internationally recognized expertise in studying and testing hypothesis-based targeted therapy in oncology. Specifically, the successful candidate will be involved in VHIO´s molecular prescreening program to analyze tissue-based biomarkers by immunohistochemistry and fluorescent in situ hybridization.
He/she will also participate in multiple clinical trials for which our group acts as central or local laboratory as well as collaborate closely with our basic and translational researchers in projects aimed at gaining essential insights into basic cancer biology, mechanisms of action, and resistance to targeted therapies. If interested, he/she may also have the opportunity to join a PhD program of the Universitat Autónoma de Barcelona (UAB).
Requirements (degree, experience, additional training):
A highly driven research-oriented pathologist with the following minimum requirements and experience:
- Degree in Medicine
· Board-certification in Pathology
· Fluency in English is mandatory
· Experience in working in similar positions will be favourably considered
Candidates should submit a cover letter describing their research interests, curriculum vitae, and names and contact information for 2-3 references via email to: rrhh@vhio.net. Please specify ´Pathologist Position´ in the subject line.
Additional Information:
Established in 2006, the Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain, is a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.
Undertaking one of Spain´s most dynamic cancer research programs, VHIO is dedicated to delivering on the promise of precision medicine in oncology – turning cancer discovery into more effective, tailored treatments and better practice for the care of our patients.
Marking a new chapter in VHIO´s evolution and affording us with the valuable space through which to grow, our new home since September last year – the CELLEX Building, now brings all our teams under the same roof which is instrumental in further enhancing collaboration and the connection between our various programs.
A dynamic, multidisciplinary research environment, optimal laboratory space and access to our cutting-edge core technologies: Molecular Oncology, Cancer Genomics, Translational Genomics, and Proteomics which are not only responsible for the development of VHIO´s core technologies and platforms but also pursue, implement and develop their own independent research lines and projects. Located in the stunning city that is Barcelona, our exceptional facilities also comprise a state-of-the-art animal facility with a dedicated surface area of 1347 m2 and a capacity of 5471 cages.
To discover more about VHIO, its Faculty, research programs and activities visit: www.vhio.net.
Where to apply: rrhh@vhio.net
